EX-99 2 a07-14559_1ex99.htm EX-99

EXHIBIT 99

FOR IMMEDIATE RELEASE

RETRACTABLE TECHNOLOGIES, INC. REPORTS $5.8 MILLION IN FIRST QUARTER REVENUES AS UNIT SALES INCREASE 61.5%

LITTLE ELM, Texas, May 16, 2007—Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, today reported revenues of $5.8 million for the three months ended March 31, 2007, an increase of 4.5% over the same 2006 period. Unit sales rose 61.5%. These gains were due largely to higher international sales volumes, primarily through the Global HIV/AIDS initiative.

The loss applicable to common shareholders in the first quarter widened to $2.6 million from $1.0 million in 2006. This resulted from lower average sales prices, which reduced the profit margin to 21.8% in 2007 from 34.6% in 2006.  The Company also incurred higher sales and marketing expenses as well as general and administrative costs. Sales and marketing compensation costs and travel and entertainment expense rose as the Company continued to build its national sales force. General and administrative costs increased principally due to higher legal costs.

Income tax benefits for the first quarter of 2007 are fully reserved. In contrast, the benefit for income taxes of $289,000 in the same period last year consisted primarily of federal taxes subject to carry back provisions.  State income taxes are also subject to the various states’ carry back rules.

Further details are available in our Form 10-Q filed on May 15, 2007, with the Securities and Exchange Commission.

Retractable Technologies, Inc. manufactures and markets VanishPoint® automated retraction safety syringes and blood collection devices, which virtually eliminate health care worker exposure to accidental needlestick injuries. These revolutionary devices use a patented friction ring mechanism that causes the contaminated needle to retract automatically from the patient into the barrel of the device, a feature that is designed to prevent reuse. VanishPoint® safety needle devices are distributed by various specialty and general line distributors. For more information on Retractable, visit our Web site at www.vanishpoint.com.

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect the Company’s current views with respect to future events. The Company believes that the expectations reflected in such forward-looking statements are accurate. However, the Company cannot assure you that such expectations will materialize. The Company’s actual future performance could differ materially from such statements.

Factors that could cause or contribute to such differences include, but are not limited to: the Company’s ability to maintain liquidity; maintenance of the Company’s patent protection; the impact of current litigation; the impact of dramatic increases in demand; the Company’s ability to maintain and quickly increase its production capacity in the




event of a dramatic increase in demand; the Company’s ability to access the market; the Company’s ability to decrease production costs; the Company’s ability to continue to finance research and development as well as operations and expansion of production; the increased interest of other larger market players, specifically Becton Dickinson and Company, Inc., in providing safety needle devices to their customers; and other risks and uncertainties that are detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.




RETRACTABLE TECHNOLOGIES, INC.
CONDENSED BALANCE SHEETS

 

 

 

 

December 31,

 

 

 

March 31, 2007

 

2006

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

45,302,332

 

$

46,814,689

 

Accounts receivable, net

 

2,550,762

 

1,956,756

 

Inventories, net

 

6,989,837

 

6,385,780

 

Income taxes receivable

 

2,357,811

 

2,355,732

 

Other current assets

 

336,372

 

267,707

 

Total current assets

 

57,537,114

 

57,780,664

 

 

 

 

 

 

 

Property, plant, and equipment, net

 

12,041,764

 

12,212,140

 

Intangible assets, net

 

376,401

 

279,846

 

Other assets

 

508,898

 

522,294

 

Total assets

 

$

70,464,177

 

$

70,794,944

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

5,591,786

 

$

4,247,630

 

Current portion of long-term debt

 

281,075

 

261,905

 

Accrued compensation

 

632,041

 

472,573

 

Dividends payable

 

979,193

 

 

Marketing fees payable

 

1,419,760

 

1,419,760

 

Accrued royalties to a shareholder

 

442,155

 

2,755

 

Other accrued liabilities

 

499,587

 

440,253

 

Current deferred tax liability

 

39,159

 

45,697

 

Total current liabilities

 

9,884,756

 

6,890,573

 

 

 

 

 

 

 

Long-term debt, net of current maturities

 

4,054,542

 

4,137,231

 

Long-term deferred tax liability

 

51,290

 

56,828

 

Total liabilities

 

13,990,588

 

11,084,632

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock $1 par value:

 

 

 

 

 

Series I, Class B

 

144,000

 

164,000

 

Series II, Class B

 

224,700

 

224,700

 

Series III, Class B

 

135,245

 

135,245

 

Series IV, Class B

 

553,500

 

553,500

 

Series V, Class B

 

1,338,721

 

1,363,721

 

Common stock, no par value

 

 

 

Additional paid-in capital

 

53,793,468

 

54,709,108

 

Retained earnings

 

283,955

 

2,560,038

 

Total stockholders’ equity

 

56,473,589

 

59,710,312

 

Total liabilities and stockholders’ equity

 

$

70,464,177

 

$

70,794,944

 

 




RETRACTABLE TECHNOLOGIES, INC.
CONDENSED STATEMENTS OF OPERATIONS
(unaudited)

 

 

Three Months
Ended
March 31, 2007

 

Three Months
Ended
March 31, 2006

 

 

 

 

 

 

 

Sales, net

 

$

5,773,823

 

$

3,881,805

 

Reimbursed discounts

 

 

1,640,925

 

Total sales

 

5,773,823

 

5,522,730

 

Cost of sales

 

4,514,314

 

3,611,190

 

Gross profit

 

1,259,509

 

1,911,540

 

 

 

 

 

 

 

Total operating expenses:

 

3,999,995

 

3,151,972

 

Loss from operations

 

(2,740,486

)

(1,240,432

)

 

 

 

 

 

 

Interest and other income

 

541,197

 

462,197

 

Interest expense, net

 

(76,794

)

(110,707

)

Net loss before income taxes

 

(2,276,083

)

(888,942

)

Benefit for income taxes

 

 

(289,004

)

Net loss

 

(2,276,083

)

(599,938

)

Preferred stock dividend requirements

 

(355,051

)

(367,078

)

Loss applicable to common shareholders

 

$

(2,631,134

)

$

(967,016

)

 

 

 

 

 

 

Loss per share - basic and diluted

 

$

(0.11

)

$

(0.04

)

 

 

 

 

 

 

Weighted average common shares outstanding

 

23,676,664

 

23,521,551

 

 

Investor Contact:

Douglas W. Cowan

Vice President and Chief Financial Officer

(888) 806-2626 or (972) 294-1010

 rtifinancial@vanishpoint.com

Media Contact:

Phillip L. Zweig

Communications Director

(212) 490-0811 or (214) 912-7415 (cell)

plzweig@aol.com